Cover Image

Intraocular Metastasis as the Presenting Symptom of NSCLC and the Role of Bevacizumab: A Case Report

Madiha Iqbal, Sam S. Dahr, Wajeeha Razaq, Mohammad Razaq

Abstract


Introduction: Metastasis to the eye is a rare clinical entity accounting for about 2-9% ocular malignancies. Clinical awareness can lead to prompt diagnosis and appropriate management.

Case presentation: We here present a case of a 60-year-old patient who visited to several ophthalmologists with the complaint of blurry vision in his left eye. He was diagnosed with anterior uveitis and elevated intraocular pressure. A masquerade syndrome was suspected, and anterior chamber paracentesis was performed, which revealed metastatic non-small cell lung cancer (NSCLC). CT chest revealed a left lung mass with right paratracheal lymphadenopathy. No other evidence of metastatic disease was found on PET/CT scan and MRI of the brain. He received treatment for stage IV lung cancer with carboplatin, paclitaxel, and bevacizumab. The intraocular tumor cell infiltration was treated with intravitreal bevacizumab that resulted in subjective and objective improvement.

Conclusion: Metastasis to the eye may present in a masquerade-like fashion as intraocular inflammation. Tumor specific therapy directed locally within the eye may be a component of an overall treatment plan.


 


Keywords


Lung cancer; ocular metastasis; bevacizumab; non-small cell lung cancer

Full Text:

PDF

References


Jiang, K., Brownstein, S., Sekhon, H. S., Laurie, S. A., Lam, K., Gilberg, S., & Britton, W. (2013). Ocular metastasis of lung adenocarcinoma with ELM4-ALK translocation: A case report with a review of the literature. Saudi J Ophthalmol. 27(3):187-192

Aragao RE, Barreira IM, Gomes LM, Bastos AS, & Beserra FdeF. Choroidal metastasis as the first sign of bronchioloalveolar lung cancer: case report. Arq Bras Oftalmol. 2013, 76 (4):250-252

Asteriou C, Konstantinou D, Kleontas A, Paliouras D, Samanidis G, Papadopoulou F, & Barbetakis N. Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: a case report. World J Surg Oncol. 2010, 8, 2

Shields CL, Shields JA, Gross NE, Schwartz GP, & Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997, 104(8):1265-1276

de la Barquera Cordero AS, & Hidalgo RA. Intravitreal bevacizumab for choroidal metastasis of lung carcinoma; a case report. J Ophthalmic Vis Res. 2010, 5(4):265-268.

Kuo IC, Haller JA, Maffrand R, Sambuelli RH, & Reviglio VE. Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment. Arch Ophthalmol. 2008, 126(9):1311-1313

Subramanian J, & Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007, 25(5):561-570

Kim SW, Kim MJ, Huh K, & Oh J. Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy. Ophthalmologica. 2009, 223(6):411-413

Lam, M., Lee, J., Teoh, S., & Agrawal, R. Choroidal metastasis as the presenting feature of a non-small cell lung carcinoma with no apparent primary lesion identified by X-ray: A case report. Oncol Lett. 2014, 8(4):1886-1888

Lin AD, & Wong WK Jr. A case study of unusual etiology of anterior uveitis with ocular hypertension-iris metastasis of primary lung adenocarcinoma. Hawaii J Med Public Health. 2014, 73(3), 89-90

Liu A, Saman H, & Pusalkar P. Unilateral temporal haemianopia in a patient with non-small cell lung cancer: intraocular metastasis despite chemotherapy. BMJ Case Rep. 2011. doi: 10.1136/bcr.06.2011.4327

Nikratowicz D, Rospond-Kubiak I, & Kociecki J. Small-cell lung carcinoma metastasis to the iris - case presentation. Contemp Oncol (Pozn). 2013, 17(3):331-333

Yao HY, Horng CT, Chen JT, & Tsai ML. Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab. Acta Ophthalmol. 2010, 88(7):e282-283

Herbst RS, Johnson DH, Mininberg E, Carbone DP, Henderson T, Kim ES, Sandler A. Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer. J Clin Oncol. 2005, 23(11):2544-2555

Kreusel KM, Wiegel T, Stange M, Bornfeld N, Hinkelbein W, & Foerster MH. Choroidal metastasis in disseminated lung cancer: frequency and risk factors. Am J Ophthalmol. 2002, 134(3):445-447

Maturu VN, Singh N, Bansal P, Rai Mittal B, Gupta N, Behera D, Gupta A. Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature. Med Oncol. 2014, 31(4):901


Refbacks

  • There are currently no refbacks.


AJCC-REP (ISSN 2572-5742)Copyright © 2012-2020. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States